Study on Androgen Receptor and Triple Negative Breast Cancer

Clinical trial NCT03383679 · COMPLETED

Trial details

NCT number: NCT03383679
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Female Triple Negative and Androgen Receptor Positive

Start date: 2018-03-14
Primary completion: 2021-11-30
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.